A detailed history of Cibc World Markets Corp transactions in Eli Lilly & CO stock. As of the latest transaction made, Cibc World Markets Corp holds 108,185 shares of LLY stock, worth $80.9 Million. This represents 0.71% of its overall portfolio holdings.

Number of Shares
108,185
Previous 103,464 4.56%
Holding current value
$80.9 Million
Previous $93.7 Million 2.32%
% of portfolio
0.71%
Previous 0.62%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$772.14 - $960.02 $3.65 Million - $4.53 Million
4,721 Added 4.56%
108,185 $95.8 Million
Q2 2024

Aug 12, 2024

SELL
$724.87 - $909.04 $11.5 Million - $14.4 Million
-15,863 Reduced 13.29%
103,464 $93.7 Million
Q1 2024

May 13, 2024

BUY
$592.2 - $792.28 $9.72 Million - $13 Million
16,421 Added 15.96%
119,327 $92.8 Million
Q4 2023

Feb 13, 2024

BUY
$525.19 - $619.13 $30.9 Million - $36.5 Million
58,894 Added 133.81%
102,906 $60 Million
Q3 2023

Nov 13, 2023

SELL
$434.7 - $599.3 $21 Million - $29 Million
-48,326 Reduced 52.34%
44,012 $23.6 Million
Q2 2023

Aug 04, 2023

BUY
$350.74 - $468.98 $18.4 Million - $24.6 Million
52,457 Added 131.53%
92,338 $43.3 Million
Q1 2023

May 11, 2023

SELL
$310.63 - $364.82 $63 Million - $74 Million
-202,837 Reduced 83.57%
39,881 $13.7 Million
Q4 2022

Feb 09, 2023

BUY
$321.55 - $374.67 $74.2 Million - $86.5 Million
230,751 Added 1928.23%
242,718 $88.8 Million
Q3 2022

Nov 14, 2022

SELL
$296.48 - $337.87 $12.8 Million - $14.6 Million
-43,087 Reduced 78.26%
11,967 $3.87 Million
Q2 2022

Aug 12, 2022

SELL
$278.73 - $327.27 $30.2 Million - $35.4 Million
-108,286 Reduced 66.29%
55,054 $17.9 Million
Q1 2022

May 13, 2022

BUY
$234.69 - $291.66 $3.19 Million - $3.97 Million
13,601 Added 9.08%
163,340 $46.8 Million
Q4 2021

Feb 11, 2022

SELL
$224.85 - $279.04 $6.61 Million - $8.21 Million
-29,412 Reduced 16.42%
149,739 $41.4 Million
Q3 2021

Nov 12, 2021

BUY
$221.6 - $272.71 $21.9 Million - $26.9 Million
98,737 Added 122.79%
179,151 $41.4 Million
Q2 2021

Aug 10, 2021

SELL
$180.55 - $233.54 $960,887 - $1.24 Million
-5,322 Reduced 6.21%
80,414 $18.5 Million
Q1 2021

May 07, 2021

SELL
$164.32 - $212.72 $9.95 Million - $12.9 Million
-60,560 Reduced 41.4%
85,736 $16 Million
Q4 2020

Feb 12, 2021

SELL
$130.46 - $172.63 $4.06 Million - $5.37 Million
-31,117 Reduced 17.54%
146,296 $24.7 Million
Q3 2020

Nov 12, 2020

BUY
$146.22 - $169.13 $13.8 Million - $16 Million
94,719 Added 114.54%
177,413 $26.3 Million
Q2 2020

Aug 12, 2020

BUY
$136.42 - $164.18 $2.85 Million - $3.42 Million
20,857 Added 33.73%
82,694 $13.6 Million
Q1 2020

May 12, 2020

SELL
$119.05 - $147.35 $32 Million - $39.6 Million
-268,672 Reduced 81.29%
61,837 $8.58 Million
Q4 2019

Feb 13, 2020

SELL
$106.92 - $132.43 $2.12 Million - $2.62 Million
-19,809 Reduced 5.65%
330,509 $43.4 Million
Q3 2019

Nov 12, 2019

BUY
$106.79 - $116.16 $15.9 Million - $17.3 Million
148,767 Added 73.81%
350,318 $39.2 Million
Q2 2019

Aug 13, 2019

SELL
$110.79 - $129.32 $18.1 Million - $21.1 Million
-163,125 Reduced 44.73%
201,551 $22.3 Million
Q1 2019

May 14, 2019

BUY
$111.31 - $131.02 $6.56 Million - $7.72 Million
58,901 Added 19.26%
364,676 $47.3 Million
Q4 2018

Feb 13, 2019

BUY
$105.9 - $118.64 $4.39 Million - $4.92 Million
41,475 Added 15.69%
305,775 $35.4 Million
Q3 2018

Nov 13, 2018

BUY
$85.86 - $107.31 $4.47 Million - $5.58 Million
52,022 Added 24.51%
264,300 $28.4 Million
Q2 2018

Aug 13, 2018

BUY
$75.7 - $86.88 $2.54 Million - $2.92 Million
33,560 Added 18.78%
212,278 $18.1 Million
Q1 2018

May 11, 2018

SELL
$74.21 - $87.6 $15.8 Million - $18.6 Million
-212,889 Reduced 54.36%
178,718 $13.8 Million
Q4 2017

Feb 13, 2018

BUY
$81.94 - $87.89 $18.4 Million - $19.7 Million
224,198 Added 133.92%
391,607 $33.1 Million
Q3 2017

Nov 14, 2017

BUY
$77.07 - $85.54 $12.9 Million - $14.3 Million
167,409
167,409 $14.3 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $711B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Cibc World Markets Corp Portfolio

Follow Cibc World Markets Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc World Markets Corp, based on Form 13F filings with the SEC.

News

Stay updated on Cibc World Markets Corp with notifications on news.